enVVeno Medical Corporation – NASDAQ:NVNOW

Financial Health
0
1
2
3
4
5
6
7
8
9

enVVeno Medical stock price monthly change

-91.43%
month

enVVeno Medical stock price quarterly change

-91.43%
quarter

enVVeno Medical stock price yearly change

-96.55%
year

enVVeno Medical key metrics

Market Cap
45.82M
Enterprise value
N/A
P/E
-0.02
EV/Sales
N/A
EV/EBITDA
0.09
Price/Sales
N/A
Price/Book
0.01
PEG ratio
N/A
EPS
-1.75
Revenue
N/A
EBITDA
-23.99M
Income
-22.11M
Revenue Q/Q
N/A
Revenue Y/Y
N/A
Profit margin
0%
Oper. margin
0%
Gross margin
0%
EBIT margin
0%
EBITDA margin
N/A
Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

enVVeno Medical stock price history

enVVeno Medical stock forecast

enVVeno Medical financial statements

enVVeno Medical Corporation (NASDAQ:NVNOW): Profit margin
Jun 2023 0 -6.47M
Sep 2023 0 -5.00M
Dec 2023 824K -5.64M -685.56%
Mar 2024 0 -4.99M
enVVeno Medical Corporation (NASDAQ:NVNOW): Debt to assets
Jun 2023 32086000 3.27M 10.2%
Sep 2023 28094000 3.17M 11.32%
Dec 2023 48635000 2.43M 5.01%
Mar 2024 44829000 2.46M 5.49%
enVVeno Medical Corporation (NASDAQ:NVNOW): Cash Flow
Jun 2023 -4.56M 7.00M 0
Sep 2023 -4.21M 4.44M 0
Dec 2023 -4.97M -22.14M 25.79M
Mar 2024 -3.54M 2.19M 46K

enVVeno Medical alternative data

enVVeno Medical Corporation (NASDAQ:NVNOW): Employee count
Aug 2023 30
Sep 2023 30
Oct 2023 30
Nov 2023 30
Dec 2023 30
Jan 2024 30
Feb 2024 30
Mar 2024 30
Apr 2024 30
May 2024 30
Jun 2024 30
Jul 2024 30

enVVeno Medical other data

0.01% -0.05%
of NVNOW is owned by hedge funds
500 -4.27K
shares is hold by hedge funds

enVVeno Medical Corporation (NASDAQ:NVNOW): Insider trades (number of shares)
Period Buy Sel
Nov 2021 4000 0
Jun 2022 3500 0
Aug 2022 7751 0
Transaction Date Insider Security Shares Price per share Total value Source
Option
JENUSAITIS MATTHEW director
Restricted Stock Units 1,041 N/A N/A
Option
JENUSAITIS MATTHEW director
Common Stock 1,041 N/A N/A
Option
GRAY ROBERT director
Restricted Stock Units 1,041 N/A N/A
Option
GRAY ROBERT director
Common Stock 1,041 N/A N/A
Purchase
DUHAY FRANCIS director
Common Stock 7,751 $6.14 $47,591
Purchase
SHRIVASTAVA SANJAY director
Common Stock 1,000 $3.85 $3,850
Purchase
BERMAN ROBERT ANDREW director, officer: Chief Execut..
Common Stock 2,500 $3.8 $9,500
Purchase
BERMAN ROBERT ANDREW director, officer: CEO
Common Stock 2,000 $7.43 $14,860
Option
SHRIVASTAVA SANJAY director
Restricted Stock Units 388 N/A N/A
Option
SHRIVASTAVA SANJAY director
Common Stock 388 N/A N/A
  • When is enVVeno Medical's next earnings date?

    Unfortunately, enVVeno Medical's (NVNOW) next earnings date is currently unknown.

  • Does enVVeno Medical pay dividends?

    No, enVVeno Medical does not pay dividends.

  • How much money does enVVeno Medical make?

    enVVeno Medical has a market capitalization of 45.82M.

  • What is enVVeno Medical's stock symbol?

    enVVeno Medical Corporation is traded on the NASDAQ under the ticker symbol "NVNOW".

  • What is enVVeno Medical's primary industry?

    Company operates in the Healthcare sector and Medical - Devices industry.

  • How do i buy shares of enVVeno Medical?

    Shares of enVVeno Medical can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does enVVeno Medical have?

    As Jul 2024, enVVeno Medical employs 30 workers.

  • When enVVeno Medical went public?

    enVVeno Medical Corporation is publicly traded company for more then 7 years since IPO on 14 Jun 2018.

  • What is enVVeno Medical's official website?

    The official website for enVVeno Medical is envveno.com.

  • Where are enVVeno Medical's headquarters?

    enVVeno Medical is headquartered at 70 Doppler, Irvine, CA.

  • How can i contact enVVeno Medical?

    enVVeno Medical's mailing address is 70 Doppler, Irvine, CA and company can be reached via phone at +94 92612900.

enVVeno Medical company profile:

enVVeno Medical Corporation

envveno.com
Exchange:

NASDAQ

Full time employees:

30

Industry:

Medical - Devices

Sector:

Healthcare

enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency. Its VenoValve is implanted in the femoral vein and acts as a one-way valve to help restore proper blood flow in the leg. The company was formerly known as Hancock Jaffe Laboratories, Inc. and changed its name to enVVeno Medical Corporation in October 2021. enVVeno Medical Corporation was incorporated in 1999 and is based in Irvine, California.

70 Doppler
Irvine, CA 92618

CIK: 0001661053
:
CUSIP: 29415J114